Peptide Exchange System for MHC Tetramer Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current techniques for detecting antigen-specific CD8+ T cells using MHC class I tetramers are limited by the stability of peptide binding, making it difficult to exchange peptides without affecting the integrity of the MHC complex, which is necessary for studying different antigen-specific populations.
Innovation Solution
The development of methods for performing peptide exchange on MHC class I and II molecules, allowing for the creation of MHC class I tetramers with high peptide exchangeability, enabling the replacement of peptides while maintaining the integrity of the MHC complex, and providing compositions and kits for performing these methods.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If peptides bind tightly to MHC heavy chain with high affinity, then the MHC complex integrity is maintained, but peptide exchangeability is reduced
Solution Approach 1:
The patent applies parameter changes by modifying the binding affinity parameters of peptides to MHC molecules. Specifically, it uses peptides with optimized binding affinities that allow exchange while maintaining complex integrity. The patent describes using peptides with Kd values in the nanomolar range that enable controlled exchange kinetics, transforming the static binding parameter into a dynamic control mechanism for peptide replacement.
Solution Approach 2:
The patent employs an intermediary mechanism through the use of peptide exchange factors and competitive peptides. These intermediaries facilitate the exchange process by temporarily binding to the MHC molecule, creating a opportunity for the incoming peptide to displace the outgoing peptide. This mediator approach allows exchange to occur without compromising the overall stability of the MHC complex.
2Adaptability or versatility
If peptides are exchanged in MHC tetramers, then different antigen-specific populations can be studied, but the stability of the MHC complex is affected
Solution Approach 1:
The patent applies segmentation by treating the MHC tetramer as a modular system where individual peptide-MHC monomers can be exchanged independently while maintaining the overall tetrameric structure. This allows different antigen-specific populations to be studied by exchanging peptides in each monomer without destabilizing the entire complex, as each monomer maintains its structural integrity.
Solution Approach 2:
The patent uses parameter changes in peptide binding affinity and exchange kinetics to maintain MHC complex stability during peptide exchange. By carefully selecting peptides with appropriate binding parameters and controlling exchange conditions (temperature, concentration, time), the patent achieves peptide replacement without compromising the structural stability of the tetrameric complex.
3Adaptability or versatility
If conventional peptide exchange techniques are used, then peptide replacement is achieved, but quantification of exchange is not possible
Solution Approach 1:
The patent applies color changes through the use of fluorescently labeled peptides and MHC molecules. By incorporating fluorophores with distinct emission wavelengths, the patent enables quantitative detection of peptide exchange through flow cytometry. The fluorescent signal intensity directly correlates with the amount of exchanged peptide, providing precise quantification of exchange efficiency and kinetics.
Solution Approach 2:
The patent replaces mechanical/visual detection methods with fluorescent-based quantification systems. Instead of relying on indirect or qualitative assessment of peptide exchange, the patent uses fluorescent labeling and flow cytometry to directly measure and quantify the exchange process, enabling precise measurement of exchange parameters such as rate constants and equilibrium constants.
Data Source
AI summary
The methods disclosed in the present disclosure allow quantified exchange of peptides into MHC proteins. These methods allow MHC proteins with exchanged peptides to be used in further applications such as cell staining. The methods may also be used to quantify peptides present in complex mixtures.